IP Library Assignment 060223/0878
Patent Assignment
Reel/Frame 060223/0878

Assignment of Assignor's Interest

Recorded: 2022-06-16 Pages: 14
Assignor
Assignee
AXSOME MALTA LTD.
78 MILL STREET, ZONE 5, CENTRAL BUSINESS DISTRICT, QORMI, CBD 5090, MALTA
Covered Properties (36)
Treatment of Cataplexy
Patent: 9,359,290 →
Application: 14/205,423 →
Publication: US 2014/0275244
Promotion of Smoking Cessation
Application: 14/328,795 →
Publication: US 2015/0018414
Treatment for Obesity
Patent: 9,226,910 →
Application: 14/334,694 →
Publication: US 2015/0025136
Treatment for Obesity
Patent: 9,649,291 →
Application: 14/955,646 →
Publication: US 2016/0081970
Treatment of Cataplexy
Patent: 9,585,863 →
Application: 15/149,478 →
Publication: US 2016/0250176
Treatment of Cataplexy
Application: 15/419,133 →
Publication: US 2017/0137375
Treatment for Obesity
Application: 15/594,070 →
Publication: US 2017/0340596
Treatment for Obesity
Application: 16/144,247 →
Publication: US 2019/0099395
Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate
Application: 16/225,890 →
Publication: US 2019/0117578
Solvate Form of (R)-2-amino-3-phenylpropyl carbamate
Application: 16/331,069 →
Publication: US 2019/0194126
Carbamoyl Phenylalaninol Compounds and Uses Thereof
Application: 16/338,925 →
Publication: US 2019/0218175
Treatment of Cataplexy
Application: 16/359,446 →
Publication: US 2019/0218174
Methods and Compositions for Treating Excessive Sleepiness
Application: 16/618,735 →
Publication: US 2020/0163927
Carbamoyl Phenylalaninol Analogs and Uses Thereof
Application: 16/634,935 →
Publication: US 2021/0093603
Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate
Application: 16/689,715 →
Publication: US 2020/0085748
Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function
Application: 16/824,560 →
Methods and Compositions for Treating Excessive Sleepiness
Application: 16/877,717 →
Publication: US 2020/0281886
Carbamoyl Phenylalaninol Compounds and Uses Thereof
Application: 16/891,464 →
Publication: US 2020/0290955
Treatment for Obesity
Application: 17/028,674 →
Publication: US 2021/0077450
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
Application: 17/091,222 →
Publication: US 2021/0053912
Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function
Application: 17/149,406 →
Publication: US 2021/0290589
Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate
Application: 17/154,336 →
Publication: US 2021/0205227
Methods and Compositions for Treating Excessive Sleepiness
Application: 17/212,079 →
Publication: US 2021/0205257
Treatment of Cataplexy
Application: 17/383,707 →
Publication: US 2022/0017457
Carbamoyl Phenylalaninol Compounds and Uses Thereof
Application: 17/470,063 →
Publication: US 2022/0098145
Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function
Application: 17/479,121 →
Publication: US 2022/0000831
Treatment of Cataplexy
Application: 61/778,998 →
Promotion of Smoking Cessation
Application: 61/845,438 →
Treatment for Obesity
Application: 61/847,593 →
Formulations of (R)-2-amino-3-phenylpropyl carbamate
Application: 62/383,818 →
Solvate Form of (R)-2-amino-3-phenylpropyl carbamate
Application: 62/383,822 →
Carbamoyl Phenylalaninol Compounds and Uses Thereof
Application: 62/404,917 →
Methods and Compositions for Treating Excessive Sleepiness
Application: 62/514,176 →
Carbamoyl Phenylalaninol Analogs and Uses Thereof
Application: 62/539,088 →
Methods and Compositions for Ameliorating Biomarkers Associated with Cardiovascular Risk Using (R)-2-Amino-3-Phenylpropyl Carbamate
Application: 63/240,422 →
Methods and Compositions for Treating Cognitive Impairment
Application: 63/279,805 →
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 29, 2014
From: KHAYRALLAH, MOISE A.; BREAM, GARY; BUTTS, STEPHEN E.
To: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; SK BIOPHARMACEUTICALS CO., LTD.
Reel/Frame 033414/0487 →
Assignment of Assignor's Interest Mar 17, 2015
From: KHAYRALLAH, MOISE A; BREAM, GARY; BUTTS, STEPHEN E.
To: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; SK BIOPHARMACEUTICALS CO., LTD.
Reel/Frame 035180/0113 →
Assignment of Assignor's Interest Apr 7, 2015
From: KHAYRALLAH, MOISE A.; BREAM, GARY; BUTTS, STEPHEN E.
To: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; SK BIOPHARMACEUTICALS CO., LTD.
Reel/Frame 035350/0091 →
Security Agreement Jun 19, 2015
From: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 035936/0200 →
Assignment of Assignor's Interest Jul 3, 2019
From: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 049666/0456 →
Assignment of Assignor's Interest Oct 7, 2019
From: HURLEY, FIONN
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 050636/0903 →
Assignment of Assignor's Interest Oct 7, 2019
From: AMRI SSCI, LLC
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 050641/0673 →
Assignment of Assignor's Interest Oct 7, 2019
From: NELSON, JENNIFER LEIGH
To: AMRI SSCI, LLC
Reel/Frame 050636/0946 →
Assignment of Assignor's Interest Apr 30, 2020
From: ZOMORODI, KATAYOUN
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 052542/0740 →
Assignment of Assignor's Interest May 18, 2020
From: CARTER, LAWRENCE PATRICK
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 052688/0015 →
Assignment of Assignor's Interest May 19, 2020
From: HURLEY, FIONN; CARTER, LAWRENCE PATRICK
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 052708/0903 →
Assignment of Assignor's Interest Aug 4, 2020
From: HURLEY, FIONN
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 053393/0077 →
Assignment of Assignor's Interest Nov 2, 2020
From: ZOMORODI, KATAYOUN
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 054235/0638 →
Assignment of Assignor's Interest Feb 25, 2021
From: ZHANG (LEGAL REPRESENTATIVE OF THE ESTATE OF DECEASED INVENTOR YUAN LU), HAO
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 055416/0576 →
Security Agreement May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
Release of Security Interest May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
Reel/Frame 056150/0708 →
Security Interest Sep 9, 2024
From: AXSOME MALTA LTD
To: HERCULES CAPITAL, INC.
Reel/Frame 068900/0023 →
Release of Security Interest May 6, 2025
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 071034/0467 →
Security Interest May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →